Showing results (1-10 of 186) with videos related to
Sort By:
Pageof 19
Handbook of Experimental Pharmacology|December 18, 2008
NO and sGC-stimulating NO donorsIan L Megson, Mark R MillerCurrent Opinion in Investigational Drugs (London, England : 2000)|April 1, 2009
LA-419, a nitric-oxide donor for the treatment of cardiovascular disordersIan L Megson, Stephen J LeslieThe Journal of Physiology|June 26, 2003
Nitric oxide and the mechanism of rat vascular smooth muscle photorelaxationFrederick Werner Flitney, Ian L MegsonExpert Opinion on Investigational Drugs|May 9, 2002
Nitric oxide donor drugs: current status and future trendsIan L Megson, David J WebbPharmacology & Therapeutics|October 2, 2013
Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefitsGordon F Rushworth, Ian L MegsonClinical Toxicology (Philadelphia, Pa.)|December 8, 2019
Does oxidative stress contribute to toxicity in acute organophosphorus poisoning? - a systematic review of the evidenceLekaashree Rambabu, Ian L Megson, Michael EddlestonCardiovascular Research|March 6, 2003
A novel S-nitrosothiol causes prolonged and selective inhibition of platelet adhesion at sites of vascular injuryMark R Miller, Inderraj S Hanspal, Patrick W F Hadoke, et al.Food & Function|April 26, 2016
Lipids and cardiovascular disease: where does dietary intervention sit alongside statin therapy?Ian L Megson, Phillip D Whitfield, Ioannis ZabetakisExpert Opinion on Therapeutic Targets|November 16, 2006
Therapeutic effects of nitric oxide-aspirin hybrid drugsCatriona M Turnbull, Adriano G Rossi, Ian L MegsonBritish Journal of Pharmacology|February 3, 2005
A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerationsMichael S Crane, Adriano G Rossi, Ian L MegsonPageof 19